COBO MARC (Principal Accounting Officer) reported 1 transaction at BRIDGEBIO ONCOLOGY THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 10/5/2026ACC: 0001193125-26-414135
Officer· Principal Accounting Officer
Since Apr 2026
-126.00
Net shares
Net seller
$496.44
Total sold
0
Open market trades
0B · 0S
1
Total transactions
126.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−126.00
Price / share
$3.94
Trade value
$496.44
% of position
0.9%
10/1/2026
14.14K→14.02K
Total
Net shares
−126.00
Net value
-$496.44
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/1/2026 | F · Tax Withholding | −126.00 | $3.94 | $496.44 | 0.9% | 14.14K | 14.02K |
| Total | −126.00 | -$496.44 | ||||||
Derivative Transactions0
No derivative transactions reported